BIOMAT Database Logo BIOMAT Database Logo

[Cholestatic hepatitis caused by captopril]. 1998

F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo

UI MeSH Term Description Entries
D008297 Male Males
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002780 Cholestasis, Intrahepatic Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC). Bile Duct Obstruction, Intrahepatic,Biliary Stasis, Intrahepatic,Intrahepatic Cholestasis,Biliary Stases, Intrahepatic,Cholestases, Intrahepatic,Intrahepatic Biliary Stases,Intrahepatic Biliary Stasis,Intrahepatic Cholestases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Cholestatic hepatitis caused by gemfibrozil].
September 2001, Revista espanola de enfermedades digestivas,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
Cholestatic hepatitis caused by fluindione.
January 2002, Therapie,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
Cholestatic hepatitis caused by penicillamine.
August 1981, JAMA,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Cholestatic hepatitis caused by carbimazole].
May 1987, Presse medicale (Paris, France : 1983),
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Cholestatic hepatitis caused by cyanamide].
July 1991, Revista clinica espanola,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Cholestatic hepatitis caused by ketoconazole].
January 1988, Annales de gastroenterologie et d'hepatologie,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Toxic hepatitis caused by captopril].
January 1985, Therapie,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Cholestatic hepatitis caused by erythromycin estolate].
November 1985, Revista clinica espanola,
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Cholestatic hepatitis caused by erythromycin propionate].
December 1990, Anales de medicina interna (Madrid, Spain : 1984),
F Pérez Roldán, and P S González Carro, and M L Legaz Huidobro, and J M Saez Bravo, and F Ruiz Carrillo
[Acute cholestatic hepatitis caused by droxicam].
June 1994, Atencion primaria,
Copied contents to your clipboard!